Government ❯Regulatory Agencies ❯FDA ❯Public Health Policy

Drug Shortages

FDA Declares Semaglutide Shortage Over, Impacting Compounded Drug Market

The resolution of the Ozempic and Wegovy shortage prompts regulatory deadlines for compounding pharmacies to cease production of cheaper alternatives.

3 ARTICLES

9mo ago

FDA Reconsiders Ban on Compounded Versions of Eli Lilly's Weight Loss Drug